Compare APGE & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | CBT |
|---|---|---|
| Founded | 2022 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2023 | 1994 |
| Metric | APGE | CBT |
|---|---|---|
| Price | $72.11 | $69.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | ★ $102.40 | $70.00 |
| AVG Volume (30 Days) | ★ 799.5K | 414.0K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $3,713,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.89 |
| P/E Ratio | ★ N/A | $54.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.20 | $58.33 |
| 52 Week High | $84.56 | $89.15 |
| Indicator | APGE | CBT |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 35.69 |
| Support Level | $35.24 | $65.48 |
| Resistance Level | $82.77 | $78.03 |
| Average True Range (ATR) | 3.57 | 2.24 |
| MACD | 0.60 | -0.67 |
| Stochastic Oscillator | 79.23 | 2.30 |
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.